Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus

Conditions: T2DM (Type 2 Diabetes Mellitus) Interventions: Drug: DWP16001 0.3 mg Sponsors: Daewoong Pharmaceutical Co. LTD. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials